Harmony Biosciences Holdings, Inc. 10-K

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. Market Information Our common stock is listed and traded on the Nasdaq Global Market under the symbol “HRMY.” Holders As of February 20, 2026, we had - holders of record of our common stock. Because many of our shares of common stock are held by brokers and other institutions on behalf of shareholders, we are unable to estimate the total number of beneficial owners of our common stock represented by these holders. Performance Graph The following graph shows a comparison of the total cumulative shareholder returns of an investment of $100 in cash from December 31, 2020, through December 31, 2025, in (i) our common stock, (ii) the Nasdaq Biotechnology Index, and (iii) the Nasdaq Composite Index. The shareholder returns in the graph below are based on historical data and are not indicative of, nor intended to forecast, future performance. ​ Dividend Policy We currently intend to retain all available funds and any future earnings to fund the development and growth of our business, potential repurchase of our common stock and to repay our debt obligations, therefore we do not anticipate declaring or paying any cash dividends on our common stock in the foreseeable future. Any future determination as to the declaration and payment of dividends, if any, will be at the discretion of our board of directors, subject to compliance with contractual restrictions and covenants in the agreements governing our current and future indebtedness. Any such determination will also depend upon our business prospects, results of operations, financial condition, cash requirements and availability, industry trends and other factors that our board of directors may deem relevant. 77 Table of Contents Item 6. [Reserved]. ​